- Home
- GROV vs ESLA Comparison
GROV vs ESLA Comparison
Compare GROV & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GROV | ESLA |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | United States | United States |
| Employees | 295 | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.4M | 45.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GROV | ESLA |
|---|---|---|
| Price | $1.19 | $1.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $1.60 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 56.8K | 29.9K |
| Earning Date | 05-07-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.81 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.78 |
| 52 Week High | $1.60 | $3.15 |
Technical Indicators
Market Signals| Indicator | GROV | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 48.52 | 38.37 |
| Support Level | $1.10 | $1.00 |
| Resistance Level | $1.47 | $1.31 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 72.10 | 15.95 |
Price Performance
Historical ComparisonAbout GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with a human and environmental focus. The Company sells its products through a direct-to-consumer (DTC) platform and the Company's mobile applications, where the Company sells products from Grove-owned brands (Grove Brands) and third-parties.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.